Tafamidis
氯苯唑酸
Report date: 2026/05/15 20:01:45
NME
Base Information
Drug NameTafamidis
Drug Alias Name +[8]
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved Indications
Approved Indications in China
Original Approved Country/Territory
Original Approved Date2019/05/03
Country/Territory +[5]
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesPfizer Inc
China Registration ClassN/A
Develop Information
Active CompaniesPfizer IncFoldrx Pharmaceuticals IncPfizer Europe Ma Eeig
Inactive CompaniesN/A
Active Indications
Inactive IndicationsN/A
Other Information
ATC Code
Related LinksN/A